Literature DB >> 11749011

Clinical features on nerve gas terrorism in Matsumoto.

Hiroshi Okudera1.   

Abstract

Clinical features on the first unexpected nerve gas terrorism using sarin (isopropyl methylphosphonofluoridate) on citizens in the city of Matsumoto is described. The nerve gas terrorism occurred at midnight on 27 June, 1994. About 600 people including residents and rescue staff were exposed to sarin gas. Fifty-eight victims were admitted to hospitals and seven died. Theoretically, sarin inhibits systemic acetylcholinesterase and damages all the autonomic transmission at the muscarinic and nicotinic acetylcholine receptor. Miosis was the most common finding in the affected people. In cases with severe poisoning, organophosphate may affect the central nervous system and cause cardiomyopathy. A few of the victims complained of arrhythmia and showed a decreased cardiac contraction. Abnormal electroencephalograms were recorded in two patients. The clinical features and follow-up studies are discussed with reference to the Tokyo subway terrorism and related articles. Copyright 2002 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11749011     DOI: 10.1054/jocn.2001.1020

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

Review 1.  Acute and long-term consequences of exposure to organophosphate nerve agents in humans.

Authors:  Taiza H Figueiredo; James P Apland; Maria F M Braga; Ann M Marini
Journal:  Epilepsia       Date:  2018-08-29       Impact factor: 5.864

2.  Pathophysiology of respiratory failure following acute dichlorvos poisoning in a rodent model.

Authors:  Romolo J Gaspari; David Paydarfar
Journal:  Neurotoxicology       Date:  2007-02-11       Impact factor: 4.294

3.  Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.

Authors:  A Gore; E Bloch-Shilderman; I Egoz; J Turetz; R Brandeis
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

4.  Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury.

Authors:  Yonggang Li; Pamela J Lein; Cuimei Liu; Donald A Bruun; Cecilia Giulivi; Gregory D Ford; Teclemichael Tewolde; Catherine Ross-Inta; Byron D Ford
Journal:  Toxicol Appl Pharmacol       Date:  2012-05-11       Impact factor: 4.219

Review 5.  Clinical review: Tokyo - protecting the health care worker during a chemical mass casualty event: an important issue of continuing relevance.

Authors:  Sumie Okumura; Tetsu Okumura; Shinichi Ishimatsu; Kunihisa Miura; Hiroshi Maekawa; Toshio Naito
Journal:  Crit Care       Date:  2005-02-17       Impact factor: 9.097

Review 6.  Clinical features of organophosphate poisoning: A review of different classification systems and approaches.

Authors:  John Victor Peter; Thomas Isiah Sudarsan; John L Moran
Journal:  Indian J Crit Care Med       Date:  2014-11

7.  Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury.

Authors:  Yonggang Li; Pamela J Lein; Gregory D Ford; Cuimei Liu; Kyndra C Stovall; Todd E White; Donald A Bruun; Teclemichael Tewolde; Alicia S Gates; Timothy J Distel; Monique C Surles-Zeigler; Byron D Ford
Journal:  J Neuroinflammation       Date:  2015-04-02       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.